Perturbation of cell cycle regulators in human cancer

Cancer Surveys

Volumn 27, Issue , 1996, Pages 351-367

  Palmero, Ignacio ^a   Peters, Gordon ^a  

^a IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLINE;

CANCER; CARCINOGENESIS; CELL CYCLE; CELL DIVISION; GENE LOCATION; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW; TUMOR SUPPRESSOR GENE;

ANIMALS; CELL CYCLE; CELL CYCLE PROTEINS; HUMANS; NEOPLASMS; SIGNAL TRANSDUCTION;

EID: 0029855312     PISSN: 02612429     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (129)

1. Ajchenbaum F, Ando K, DeCaprio JA and Griffin JD (1993) Independent regulation of human D-type cyclin gene expression during G1 phase in primary T lymphocytes. Journal of Biological Chemistry 268 4113-4119
2. Ando K and Griffin JD (1995) Cdk4 integrates growth stimulatory and inhibitory signals during G1 phase of hematopoietic cells. Oncogene 10 751-755
3. Ando K, Ajchenbaum-Cymbalista F and Griffin JD (1993) Regulation of G1/S transition by cyclins D2 and D3 in hematopoietic cells. Proceedings of the National Academy of Sciences of the USA 90 9571-9575
4. Atadja P, Wong H, Veillete C and Riabowol K (1995) Overexpression of cyclin D1 blocks proliferation of normal diploid fibroblasts. Experimental Cell Research 217 205-216
5. Baldin V, Lukas J, Marcotte MJ, Pagano M and Draetta G (1993) Cyclin D1 is a nuclear protein required for cell cycle progression. Genes and Development 7 812-821
6. Bartkova J, Lukas J, Müller H, Lützhøft D, Strauss M and Bartek J (1994) Cyclin D1 protein expression and function in human breast cancer. International Journal of Cancer 57 353-361
7. Bartkova J, Lukas J, Strauss M and Bartek J (1995) Cyclin D1 oncoprotein aberrantly accumulates in malignancies of diverse histogenesis. Oncogene 10 775-778
8. Bhatia K, Fan S, Spangler G et al (1995) A mutant p21 cyclin-dependent kinase inhibitor isolated from a Burkitt's lymphoma. Cancer Research 55 1431-1435
9. Bonetta L (1994) Open questions on p16. Nature 370 180
10. Brugarolas J, Chandrasekaran C, Gordon JI, Beach D, Jacks T and Hannon GJ (1995) Radiation-induced cell cycle arrest compromised by p21 deficiency. Nature 377 552-557
11. Buckley MF, Sweeney KJE, Hamilton JA et al (1993) Expression and amplification of cyclin genes in human breast cancer. Oncogene 8 2127-2133
12. Clarke PR (1995) CAK-handed kinase activation. Current Biology 5 40-42
13. 1/S-regulatory genes. Molecular and Cellular Biology 15 4215-4224
14. Demetrick DJ, Zhang H and Beach DH (1994) Chromosomal mapping of human CDK2, CDK4, and CDK5 cell cycle kinase genes. Cytogenetics and Cell Genetics 66 72-74
15. CIP1/WAF1 Underg0 normal development, but are defective in G1 checkpoint control. Cell 82 675-684
16. Dowdy SF, Hinds PW, Louie K, Reed SI, Arnold A and Weinberg RA (1993) Physical interaction of the retinoblastoma protein with human D cyclins. Cell 73 499-511
17. 1 cyclins in senescent human diploid fibroblasts: accumulation of inactive cyclin E-Cdk2 and cyclin D1-Cdk2 complexes. Proceedings of the National Academy of Sciences of the USA 90 11034-11038
18. Duronio RJ, O'Farrell PH, Xie J-E, Brook A and Dyson N (1995) The transcription factor E2F is required for S phase during Drosophila embryogenesis. Genes and Development 9 1445-1455
19. Einhorn S and Heyman M (1993) Chromosome 9 short arm deletions in malignant diseases. Leukemia and Lymphoma 11 191-196
20. El-Deiry WS, Tokino T, Velculescu VE et al (1993) WAFI, a potential mediator of p53 tumor suppression. Cell 75 817-825
21. Elledge SJ and Harper JW (1994) Cdk inhibitors: on the threshold of checkpoints and development. Current Opinion in Cell Biology 6 847-852
22. Ewen ME, Sluss HK, Sherr CJ, Matsushime H, Kato J and Livingston DM (1993) Functional interactions of the retinoblastoma protein with mammalian D-type cyclins. Cell 73 487-497
23. Fantl V, Smith R, Brookes S, Dickson C and Peters G (1993) Chromosome 11q13 abnormalities in human breast cancer. Cancer Surveys 18 77-94
24. Flores-Rozas H, Kelman Z, Dean FB et al (1994) Cdk-interacting protein 1 directly binds with proliferating cell nuclear antigen and inhibits DNA replication catalyzed by the DNA polymerase δ holoenzyme. Proceedings of the National Academy of Sciences of the USA 91 8655-8659
25. Gao X, Chen YQ, Wu N et al (1995) Somatic mutations of the WAF1/CIP1 gene in primary prostatic cancer. Oncogene 11 1395-1398
26. Geng Y, Eaton EN, Picón M et al (1996) Regulation of cyclin E transcription by E2Fs and retinoblastoma protein. Oncogene 12 1173-1180
27. Gillett C, Fantl R, Fisher C et al (1994) Amplification and overexpression of cyclin D1 in breast cancer detected by immunohistochemical staining. Cancer Research 54 1812-1817
28. Gillett C, Smith P, Gregory W et al (1996) Cyclin D1 and prognosis in human breast cancer. International Journal of Cancer 69 1-8
29. Gonzalez-Zulueta M, Bender CM, Yang AS et al (1995) Methylation of the 5′ CpG island of the p16/CDKN2 tumor suppressor gene in normal and transformed human tissues correlates with gene silencing. Cancer Research 55 4531-4535
30. Goodrich DW and Lee W-H (1993) Molecular characterization of the retinoblastoma susceptibility gene. Biochimica et Biophysica Acta 1155 43-61
31. Gu Y, Turck CW and Morgan DO (1993) Inhibition of CDK2 activity in vivo by an associated 20K regulatory subunit. Nature 366 707-710
32. INK4/MTS2-related CDK6 inhibitor, correlates with wild-type pRb function. Genes and Development 8 2939-2952
33. Hall M and Peters G (1996) Genetic alterations of cyclins, cyclin-dependent kinases, and Cdk inhibitors in human cancer. Advances in Cancer Research 68 67-108
34. Han EK-H, Sgambato A, Jiang W et al (1995) Stable overexpression of cyclin D1 in a human mammary epithelial cell line prolongs the S-phase and inhibits growth. Oncogene 10 953-961
35. Hanna Z, Janowski M, Tremblay P et al (1993) The Vin-1 gene, identified by provirus insertional mutagenesis, is the cyclin D2. Oncogene 8 1661-1666
36. CDKN2 expression and its implication for cell immortalization and senescence. Molecular and Cellular Biology 16 859-867
37. Harper JW, Adami GR, Wei N, Keyomarsi K and Elledge SJ (1993) The p21 Cdk-interacting protein Cipl is a potent inhibitor of G1 cyclin-dependent kinases. Cell 75 805-816
38. Harris NL, Jaffe ES, Stein H et al (1994) A revised European-American classification of lymphoid neoplasms: a proposal from the international lymphoma study group. Blood 84 1361-1392
39. Hartwell LH and Weinert TA (1989) Checkpoint controls that ensure the order of cell cycle events. Science 246 629-634
40. 1 cyclins in the functional inactivation of the retinoblastoma protein. Genes and Development 8 1759-1771
41. He J, Allen JR, Collins PV et al (1994) CDK4 amplification is an alternative mechanism to p16 gene homozygous deletion in glioma cell lines. Cancer Research 54 5804-5807
42. Herber B, Truss M, Beato M and Müller R (1994) Inducible regulatory elements in the human cyclin D1 promoter. Oncogene 9 1295-1304
43. Herman JG, Merlo A, Mao L et al (1995) Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers. Cancer Research 55 4525-4530
44. Hirama T and Koeffler HP (1995) Role of the cyclin-dependent kinase inhibitors in the development of cancer. Blood 86 841-854
45. Horowitz JM, Park S-H, Bogenmann E et al (1990) Frequent inactivation of the retinoblastoma anti-oncogene is restricted to a subset of human tumor cells. Proceedings of the National Academy of Sciences of the USA 87 2775-2779
46. Jiang H, Lin J, Su Z et al (1995) The melanoma differentiation-associated gene mda-6, which encodes the cyclin-dependent kinase inhibitor p21, is differentially expressed during growth, differentiation and progression in human melanoma cells. Oncogene 10 1855-1864
47. WAF1/CiP1 in human brain tumors. Oncogene 11 2021-2028
48. Kamb A, Gruis NA, Weaver-Feldhaus J et al MH (1994) A cell cycle regulator potentially involved in genesis of many tumor types. Science 264 436-440
49. Kato J, Matsushime H, Hiebert SW, Ewen ME and Sherr CJ (1993) Direct binding of cyclin D to the retinoblastoma gene product (pRb) and pRb phosphorylation by the cyclin D-dependent kinase CDK4. Genes and Development 7 331-342
50. Kawamata N, Morosetti R, Miller CW et al (1995) Molecular analysis of the cyclin-dependent kinase inhibitor gene p27/Kip1 in human malignancies. Cancer Research 55 2266-2269
51. Keyomarsi K, O'Leary N, Molnar G, Lees E, Fingert HJ and Pardee AB (1994) Cyclin E, a potential prognostic marker for breast cancer. Cancer Research 54 380-385
52. Keyomarsi K, Conte D Jr, Toyofuku W and Fox MP (1995) Deregulation of cyclin E in breast cancer. Oncogene 11 941-950
53. Khatib ZA, Matsushime H, Valentine M, Shapiro DN, Sherr CJ and Look AT (1993) Coamplification of the CDK4 gene with MDM2 and GLI in human sarcomas. Cancer Research 53 5535-5541
54. Knudson AGJ (1971) Mutation and cancer: statistical study of retinoblastoma. Proceedings of the National Academy of Sciences of the USA 68 820-823
55. Koh J, Enders GH, Dynlacht BD and Harlow E (1995) Tumour-derived p16 alleles encoding proteins defective in cell-cycle inhibition. Nature 375 506-510
56. KIP2 gene at 11p15.5. Oncogene 12 1365-1368
57. Kranenburg O, de Groot RP, Van der Eb AJ and Zantema A (1995) Differentiation of P19 EC cells leads to differential modulation of cyclin-dependent kinase activities and to changes in the cell cycle profile. Oncogene 10 87-95
58. Lammie GA, Smith R, Silver J, Brookes S, Dickson C and Peters G (1992) Proviral insertions near cyclin D1 in mouse lymphomas: a parallel for BCL1 translocations in human B-cell neoplasms. Oncogene 7 2381-2387
59. Leach FS, Elledge SJ, Sherr CJ et al (1993) Amplification of cyclin genes in colorectal carcinomas. Cancer Research 53 1986-1989
60. KIP2, a cyclin-dependent kinase inhibitor with unique domain structure and tissue distribution. Genes and Development 9 639-649
61. Lees E (1995) Cyclin dependent kinase regulation. Current Opinion in Cell Biology 7 773-780
62. Li Y-J, Laurent-Puig P, Salmon RJ, Thomas G and Hamelin R (1995) Polymorphisms and probable lack of mutation in the WAF1-CIP1 gene in colorectal cancer. Oncogene 10 599-601
63. Lucibello FC, Sewing A, Brüsselbach S, Bürger C and Müller R (1993) Deregulation of cyclins D1 and E and suppression of cdk2 and cdk4 in senescent human fibroblasts. Journal of Cell Science 105 123-133
64. Lukas J, Müller H, Spitkovsky D et al (1994a) DNA tumor virus oncoproteins and retinoblastoma gene mutations share the ability to relieve the cell's requirement for cyclin D1 function in G1. Journal of Cell Biology 125 625-638
65. Lukas J, Pagano M, Staskova Z, Draetta G and Bartek J (1994b) Cyclin D1 protein oscillates and is essential for cell cycle progression in human tumour cell lines. Oncogene 9 707-718
66. 1 control in retinoblastoma gene-deficient cells independently of cdk4 activity. Molecular and Cellular Biology 15 2600-2611
67. Lukas J, Bartkova J, Welcker M et al (1995b) Cyclin D2 is a moderately oscillating nucleoprotein required for G1 phase progression in specific cell types. Oncogene 10 2125-2134
68. Lukas J, Parry D, Aagaard L et al (1995c) Retinoblastoma-protein-dependent cell cycle inhibition by the tumour suppressor p16. Nature 375 503-506
69. CiP1. Nature 375 159-161
70. Macleod KF, Sherry N, Hannon G et al (1995) p53-dependent and independent expression of p21 during cell growth, differentiation, and DNA damage. Genes and Development 9 935-944
71. Maelandsmo GM, Berner J-M, Flørenes VA et al (1995) Homozygous deletion frequency and expression levels of the CDKN2 gene in human sarcomas-relationship to amplification and mRNA levels of CDK4 and CCND1. British Journal of Cancer 72 393-398
72. Marx J (1994) A challenge to the p16 gene as a major tumor suppressor. Science 264 1846
73. CIP1 Cdk inhibitor family, is a candidate tumor suppressor gene. Genes and Development 9 650-662
74. Matsushime H, Roussel MF, Ashmun RA and Sherr CJ (1991) Colony-stimulating factor I regulates novel cyclins during the G1 phase of the cell cycle. Cell 65 701-713
75. Matsushime H, Quelle DE, Shurtleff SA, Shibuya M, Sherr CJ and Kato J-Y (1994) D-type cyclin-dependent kinase activity in mammalian cells. Molecular and Cellular Biology 14 2066-2076
76. INK4 requires functional retinoblastoma protein. Proceedings of the National Academy of Sciences of the USA 92 6289-6293
77. Merlo A, Herman JG, Mao L et al (1995) 5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers. Nature Medicine 1 686-692
78. 1 kinase activity for cdk6, a novel cyclin D partner. Molecular and Cellular Biology 14 2077-2086
79. Morgan DO (1995) Principles of CDK regulation. Nature 374 131-134
80. Motokura T and Arnold A (1993) Cyclins and oncogenesis. Biochimica et Biophysica Acta 1155 63-78
81. Motokura T, Bloom T, Kim HG et al (1991) A novel cyclin encoded by a bcl 1-linked candidate oncogene. Nature 350 512-515
82. 1 to complete the cell cycle. Proceedings of the National Academy of Sciences of the USA 91 8022-8026
83. Nobori T, Miura K, Wu DJ, Lois A, Takabayashi K and Carson DA (1994) Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers. Nature 368 753-756
84. Noda A, Ning Y, Venable SF, Pereira-Smith OM and Smith JR (1994) Cloning of senescent cell-derived inhibitors of DNA synthesis using an expression screen. Experimental Cell Research 211 90-98
85. Norbury C and Nurse P (1992) Animal cell cycles and their control. Annual Reviews of Biochemistry 61 441-470
86. INK4B/MTS2, and p18 genes in primary metastatic lung cancer. Cancer Research 55 1448-1451
87. KIP2 in soft tissue sarcomas and Wilms' tumors. Cancer Research 56 1219-1221
88. INK4 protein is restricted to the subset of lung cancer lines that retains wildtype RB. Oncogene 9 3375-3378
89. INK4 protein induction by 5-aza 2′ deoxycytidine. Oncogene 11 1211-1216
90. Pagano M, Theodoras AM, Tarn SW and Draetta GF (1994) Cyclin D1-mediated inhibition of repair and replicative DNA synthesis in human fibroblasts. Genes and Development 8 1627-1639
91. Pardee AB (1989) G-1 events and regulation of cell proliferation. Science 246 603-608
92. INK4/MTS1 tumour suppressor gene product. EMBO Journal 14 503-511
93. Peeper DS, van der Eb AJ and Zantema A (1994) The G1/S cell-cycle checkpoint in eukaryotic cells. Biochimica et Biophysica Acta 1198 215-230
94. Kip1 gene to 12p13 and its analysis in leukemias. Cancer Research 55 1206-1210
95. Pollock PM, Pearson JV and Hayward NK (1996) Compilation of somatic mutations of the CDKN2 gene in human cancers: non-random distribution of base substitutions. Genes Chromosomes and Cancer 15 77-88
96. KiP1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell 78 59-66
97. Kip1: chromosomal mapping to 12p12-12p13.1 and absence of mutations in human tumors. Cancer Research 55 1211-1214
98. 1 phase in rodent fibroblasts. Genes and Development 7 1559-1571
99. KIP2 gene and its analysis in the G401 Wilms' tumor assay. Cancer Research 56 1214-1218
100. Reifenberger G, J R, Ichimura K, Meltzer PS and Collins VP (1994) Amplification of multiple genes from chromosomal region 12q13-14 in human malignant gliomas: preliminary mapping of the amplicons shows preferential involvement of CDK4, SAS, and MDM2. Cancer Research 54 4299-4303
101. 1-to-S transition. Molecular and Cellular Biology 15 3463-3469
102. 1XS phase transition by expression of cyclins D1 and E with an inducible system. Molecular and Cellular Biology 14 1669-1679
103. Rosenwald IB, Lazaris-Karatzas A, Sonenberg N and Schmidt EV (1993) Elevated levels of cyclin D1 protein in response to increased expression of eukaryotic initiation factor 4E. Molecular and Cellular Biology 13 7358-7363
104. Saito M, Helin K, Valentine MB, Griffith BB, Willman CL, Harlow E and Look AT (1995) Amplification of the E2F1 transcription factor gene in the HEL erythroleukemia line. Genomics 25 130-138
105. Serrano M, Hannon GJ and Beach D (1993) A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature 366 704-707
106. Sewing A, Bürger C, Brüsselbach S, Schalk C, Lucibello FC and Müller R (1993) Human cyclin D1 encodes a labile nuclear protein whose synthesis is directly induced by growth factors and suppressed by cyclic AMP. Journal of Cell Science 104 545-554
107. INK4 expression in primary lung cancers and cell lines. Cancer Research 55 505-509
108. Sherr CJ and Roberts JM (1995) Inhibitors of mammalian G1 cyclin-dependent kinases. Genes and Development 9 1149-1163
109. Shiohara M, El-Deiry WS, Wada M et al (1994) Absence of WAF1 mutations in a variety of human malignancies. Blood 84 3781-3784
110. 1 transition during immortalization of resting human B lymphocytes by Epstein-Barr virus. EMBO Journal 13 3321-3328
111. Singh P, Wong SH and Hong W (1994) Overexpression of E2F-1 in rat embryo fibroblasts leads to neoplastic transformation. EMBO Journal 13 3329-3338
112. Stegmaier K, Takeuchi S, Golub TR et al (1996) Mutational analysis of the candidate tumor suppressor genes TEL and KIP1 in childhood acute lymphoblastic leukemia. Cancer Research 56 1413-1417
113. Strausfeld UP, Howell M, Rempel R, Mailer JL, Hunt T and Blow JJ (1994) Cipl blocks the initiation of DNA replication in Xenopus extracts by inhibition of cyclin-dependent kinases. Current Biology 4 876-883
114. ser-arg polymorphism of the WAF-1/CIP-1/p21 tumor suppressor gene in nasopharyngeal carcinoma (NPC): the polymorphism distinguishes Caucasians from Chinese. Cancer Epidemiology, Biomarkers and Prevention 4 261-267
115. sdi1/cip1/waf1 with increasing division age in both normal and SV40-transformed human fibroblasts. Oncogene 10 835-840
116. Toyoshima H and Hunter T (1994) p27, a novel inhibitor of G1 cyclin-cdk protein kinase activity, is related to p21. Cell 78 67-74
117. Waga S, Hannon GJ, Beach D and Stillman B (1994) The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA. Nature 369 574-578
118. 1 arrest in human cancer cells. Cancer Research 55 5187-5190
119. Wang JYJ, Knudsen ES and Welch PJ (1994) The retinoblastoma tumor suppressor protein. Advances in Cancer Research 64 25-85
120. Weinberg RA (1995) The retinoblastoma protein and cell cycle control. Cell 81 323-330
121. 1 progression through tetracycline-regulated expression of human cyclin E. Oncogene 9 995-997
122. Winston JT and Pledger WJ (1993) Growth factor regulation of cyclin D1 mRNA expression through protein synthesis-dependent and independent mechanisms. Molecular Biology of the Cell 4 1133-1144
123. Withers DA, Harvey RC, Faust JB, Melnyk O, Carey K and Meeker TC (1991) Characterization of a candidate bcl-1 gene. Molecular and Cellular Biology 11 4846-4853
124. Ink4a-insensitive CDK4 mutant targeted by cytolytic T lymphocytes in a human melanoma. Science 269 1281-1284
125. Won K-A, Xiong Y, Beach D and Gilman MZ (1992) Growth-regulated expression of D-type cyclin genes in human diploid fibroblasts. Proceedings of the National Academy of Sciences of the USA 89 9910-9914
126. Xiong Y, Hannon GJ, Zhang H, Casso D, Kobayashi R and Beach D (1993) p21 is a universal inhibitor of cyclin kinases. Nature 366 701-704
127. Xu G, Livingston DM and Krek W (1995) Multiple members of the E2F transcription factor family are the products of oncogenes. Proceedings of the National Academy of Sciences of the USA 92 1357-1361
128. Zhang W, Grasso L, McClain CD et al (1995) p53-independent induction of WAF1/CIP1 in human leukemia cells is correlated with growth arrest accompanying monocyte/macrophage differentiation. Cancer Research 55 668-674
129. INK4a binding domain of CDK4 in familial melanoma. Nature Genetics 12 97-99